Compare NUS & JGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NUS | JGH |
|---|---|---|
| Founded | 1984 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 469.0M | 292.3M |
| IPO Year | 1996 | N/A |
| Metric | NUS | JGH |
|---|---|---|
| Price | $10.00 | $12.73 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 446.7K | 73.9K |
| Earning Date | 02-12-2026 | 01-01-0001 |
| Dividend Yield | 2.34% | ★ 9.85% |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.20 | N/A |
| Revenue | ★ $1,560,391,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.12 | N/A |
| P/E Ratio | $4.66 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.32 | $10.36 |
| 52 Week High | $14.62 | $12.85 |
| Indicator | NUS | JGH |
|---|---|---|
| Relative Strength Index (RSI) | 49.79 | 64.42 |
| Support Level | $9.59 | $12.55 |
| Resistance Level | $10.35 | $12.66 |
| Average True Range (ATR) | 0.31 | 0.08 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 44.54 | 83.33 |
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
Nuveen Global High Income Fund operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of current income. Its securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.